Chester County News and Community Website
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), or Idera or the Company, this week is providing an update on its tilsotolimod clinical development program and providing a corporate outlook for 2020.
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced it is entering into an agreement with funds affiliated with an institutional investor providing for a private placement exempt from the registration requirements …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of therapeutic drug candidates for both oncology and rare disease indications, reported …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced the initiation of a phase 2 trial, ILLUMINATE-206 which will evaluate tilsotolimod, a toll-like receptor 9 (TLR9) agonist, in combination with nivolumab, a …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced that they have entered into an immuno-oncology clinical research collaboration with AbbVie, a global, research-based biopharmaceutical company.
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced that the company will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019 at 8:30 a.m. Eastern Time at …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of therapeutic drug candidates for both oncology and rare disease indications, reported …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of therapeutic drug candidates for both oncology and rare disease indications, announced …
Read More EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced the appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and the promotion of John J. Kirby to Chief Financial Officer. Dr. …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced that the company will present at the 2019 JMP Securities Life Sciences Conference on Thursday, June 20, 2019 at 1:30 p.m. Eastern Time …
Read More